Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|February 28, 2012
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapyKyriaki Ioannou, Pinelopi Samara, Evangelia Livaniou, et al.The International Journal of Neuropsychopharmacology|August 25, 2009
Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?Pothitos M Pitychoutis, Eirini Griva, Kyriaki Ioannou, et al.International Immunopharmacology|December 4, 2012
The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitroPinelopi Samara, Kyriaki Ioannou, Monica Neagu, et al.Journal of Immunological Methods|July 9, 2013
Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteriaPinelopi Samara, Hubert Kalbacher, Kyriaki Ioannou, et al.International Journal of Oncology|July 23, 2014
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer modelsKyriaki Ioannou, Kai Fan Cheng, Gregg V Crichlow, et al.BMC Immunology|September 24, 2013
Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopesKyriaki Ioannou, Evelyna Derhovanessian, Eleni Tsakiri, et al.European Journal of Medicinal Chemistry|May 29, 2017
New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivoPinelopi Samara, Nikoleta Christoforidou, Christelle Lemus, et al.Journal of Cellular and Molecular Medicine|February 18, 2009
Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivoSylvianna Georgaki, Margarita Skopeliti, Marinos Tsiatas, et al.Current Medicinal Chemistry|May 20, 2017
Prothymosin Alpha: An Alarmin and MorePinelopi Samara, Chrysoula-Evangelia Karachaliou, Kyriaki Ioannou, et al.Immunity & Ageing : I & A|July 10, 2015
The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent miceGee Jun Tye, Kyriaki Ioannou, Eunice Amofah, et al.Pageof 2